+
Site Tour

Search

Showing 41 - 50 of 529 results.

  • Diagnosis

    Characteristics that are strongly associated with a causal role of PFO in an ischemic stroke of unknown cause are:9 Atrial septal aneurysm (ASA) and/or a moderate-to-severe shunt Atrial septal
  • Diagnosis

    Patients with a moderate left-to-right shunt may remain asymptomatic for years. However, historical series have shown that chronic volume overload may ultimately lead to severe complications: Co
  • Overview

    LEARN MORE:​ DIAGNOSIS TREATMENT © Abbott 2025. All rights reserved. 9-EH-5-15859-01 02-2025
  • Overview

    LEARN MORE:​ DIAGNOSIS TREATMENT
  • Overview

    TREATMENT RANGE 4 MM TO 40 MM No other ASD closure device on the market today can match ASO’s wide range of device sizes.
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure LEARN MORE: PDA Symposium 2024
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  LEARN MORE: Talisman vs. Gore   Talisman vs. Occlutech THE PFO OCCLUDER
  • Clinical Data

    DEMONSTRATED SAFETY OVER NOTABLY LONG-TERM STUDIES Abbott mechanical heart valves deliver exceptional hemodynamics and performance while maintaining low complication rates over the long term. Abbott
  • Overview

    *For 27 mm valve size, measured from the farthest point of the cuff. *There is no clinical data currently available that evaluates the long-term impact of anticalcification tissue treatment in hum
  • Treatment

    EXPLORE VSD SOLUTIONS Amplatzer Muscular occluder for ventricular septal defect

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline